ote pharma uk limited
ote pharma uk limited Company Information
Group Structure
View All
Industry
Non-specialised wholesale trade
Registered Address
28 church road, stanmore, middlesex, HA7 4XR
Website
-ote pharma uk limited Estimated Valuation
Pomanda estimates the enterprise value of OTE PHARMA UK LIMITED at £424k based on a Turnover of £1.3m and 0.32x industry multiple (adjusted for size and gross margin).
ote pharma uk limited Estimated Valuation
Pomanda estimates the enterprise value of OTE PHARMA UK LIMITED at £3.5m based on an EBITDA of £895.8k and a 3.96x industry multiple (adjusted for size and gross margin).
ote pharma uk limited Estimated Valuation
Pomanda estimates the enterprise value of OTE PHARMA UK LIMITED at £3.2m based on Net Assets of £1.2m and 2.62x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ote Pharma Uk Limited Overview
Ote Pharma Uk Limited is a live company located in middlesex, HA7 4XR with a Companies House number of 09278402. It operates in the non-specialised wholesale trade sector, SIC Code 46900. Founded in October 2014, it's largest shareholder is ote holding bv with a 100% stake. Ote Pharma Uk Limited is a established, small sized company, Pomanda has estimated its turnover at £1.3m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ote Pharma Uk Limited Health Check
Pomanda's financial health check has awarded Ote Pharma Uk Limited a 5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs
5 Strong
2 Regular
5 Weak
Size
annual sales of £1.3m, make it smaller than the average company (£16.1m)
- Ote Pharma Uk Limited
£16.1m - Industry AVG
Growth
3 year (CAGR) sales growth of 63%, show it is growing at a faster rate (6.3%)
- Ote Pharma Uk Limited
6.3% - Industry AVG
Production
with a gross margin of 27.6%, this company has a comparable cost of product (27.6%)
- Ote Pharma Uk Limited
27.6% - Industry AVG
Profitability
an operating margin of 67.3% make it more profitable than the average company (5.1%)
- Ote Pharma Uk Limited
5.1% - Industry AVG
Employees
with 1 employees, this is below the industry average (41)
1 - Ote Pharma Uk Limited
41 - Industry AVG
Pay Structure
on an average salary of £44.5k, the company has an equivalent pay structure (£44.5k)
- Ote Pharma Uk Limited
£44.5k - Industry AVG
Efficiency
resulting in sales per employee of £1.3m, this is more efficient (£376.5k)
- Ote Pharma Uk Limited
£376.5k - Industry AVG
Debtor Days
it gets paid by customers after 105 days, this is later than average (51 days)
- Ote Pharma Uk Limited
51 days - Industry AVG
Creditor Days
its suppliers are paid after 10 days, this is quicker than average (31 days)
- Ote Pharma Uk Limited
31 days - Industry AVG
Stock Days
it holds stock equivalent to 146 days, this is more than average (78 days)
- Ote Pharma Uk Limited
78 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 31 weeks, this is more cash available to meet short term requirements (14 weeks)
31 weeks - Ote Pharma Uk Limited
14 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 15.6%, this is a lower level of debt than the average (47.3%)
15.6% - Ote Pharma Uk Limited
47.3% - Industry AVG
OTE PHARMA UK LIMITED financials
Ote Pharma Uk Limited's latest turnover from December 2023 is estimated at £1.3 million and the company has net assets of £1.2 million. According to their latest financial statements, Ote Pharma Uk Limited has 1 employee and maintains cash reserves of £138.5 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||
| Other Income Or Grants | |||||||||
| Cost Of Sales | |||||||||
| Gross Profit | |||||||||
| Admin Expenses | |||||||||
| Operating Profit | |||||||||
| Interest Payable | |||||||||
| Interest Receivable | |||||||||
| Pre-Tax Profit | |||||||||
| Tax | |||||||||
| Profit After Tax | |||||||||
| Dividends Paid | |||||||||
| Retained Profit | |||||||||
| Employee Costs | |||||||||
| Number Of Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 1,200 | ||||||||
| Intangible Assets | |||||||||
| Investments & Other | |||||||||
| Debtors (Due After 1 year) | |||||||||
| Total Fixed Assets | 1,200 | ||||||||
| Stock & work in progress | 387,322 | 205,633 | 248,295 | 73,496 | 115,378 | 61,348 | 52,445 | 43,789 | 37,454 |
| Trade Debtors | 385,004 | 443,890 | 192,871 | 69,274 | 93,710 | 49,505 | 51,471 | 30,740 | 14,927 |
| Group Debtors | 544,179 | 26,557 | |||||||
| Misc Debtors | 5,919 | 5,919 | 2,539 | 100 | 100 | 100 | 100 | 100 | |
| Cash | 138,539 | 240,185 | 124,040 | 109,734 | 20,824 | 23,970 | 12,427 | 28,675 | 15,449 |
| misc current assets | |||||||||
| total current assets | 1,460,963 | 922,184 | 567,745 | 252,604 | 230,012 | 134,923 | 116,443 | 103,304 | 67,830 |
| total assets | 1,462,163 | 922,184 | 567,745 | 252,604 | 230,012 | 134,923 | 116,443 | 103,304 | 67,830 |
| Bank overdraft | 50,000 | ||||||||
| Bank loan | |||||||||
| Trade Creditors | 27,744 | 36,565 | 268,772 | 8,869 | 17,065 | 18,656 | 5,243 | 12,075 | 10,819 |
| Group/Directors Accounts | 100,535 | ||||||||
| other short term finances | |||||||||
| hp & lease commitments | |||||||||
| other current liabilities | 200,894 | 230,864 | 71,083 | 25,709 | 21,001 | 15,044 | 9,269 | 6,394 | 3,162 |
| total current liabilities | 228,638 | 367,964 | 339,855 | 84,578 | 38,066 | 33,700 | 14,512 | 18,469 | 13,981 |
| loans | 250,535 | 394,035 | 438,096 | 332,895 | 337,088 | 282,077 | |||
| hp & lease commitments | |||||||||
| Accruals and Deferred Income | |||||||||
| other liabilities | 161,111 | ||||||||
| provisions | |||||||||
| total long term liabilities | 250,535 | 394,035 | 438,096 | 332,895 | 337,088 | 282,077 | 161,111 | ||
| total liabilities | 228,638 | 367,964 | 590,390 | 478,613 | 476,162 | 366,595 | 351,600 | 300,546 | 175,092 |
| net assets | 1,233,525 | 554,220 | -22,645 | -226,009 | -246,150 | -231,672 | -235,157 | -197,242 | -107,262 |
| total shareholders funds | 1,233,525 | 554,220 | -22,645 | -226,009 | -246,150 | -231,672 | -235,157 | -197,242 | -107,262 |
| Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | |
|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||
| Operating Profit | |||||||||
| Depreciation | |||||||||
| Amortisation | |||||||||
| Tax | |||||||||
| Stock | 181,689 | -42,662 | 174,799 | -41,882 | 54,030 | 8,903 | 8,656 | 6,335 | 37,454 |
| Debtors | 458,736 | 280,956 | 126,036 | -24,436 | 44,205 | -1,966 | 20,731 | 15,913 | 14,927 |
| Creditors | -8,821 | -232,207 | 259,903 | -8,196 | -1,591 | 13,413 | -6,832 | 1,256 | 10,819 |
| Accruals and Deferred Income | -29,970 | 159,781 | 45,374 | 4,708 | 5,957 | 5,775 | 2,875 | 3,232 | 3,162 |
| Deferred Taxes & Provisions | |||||||||
| Cash flow from operations | |||||||||
| Investing Activities | |||||||||
| capital expenditure | |||||||||
| Change in Investments | |||||||||
| cash flow from investments | |||||||||
| Financing Activities | |||||||||
| Bank loans | |||||||||
| Group/Directors Accounts | -100,535 | 100,535 | |||||||
| Other Short Term Loans | |||||||||
| Long term loans | -250,535 | -143,500 | -44,061 | 105,201 | -4,193 | 55,011 | 282,077 | ||
| Hire Purchase and Lease Commitments | |||||||||
| other long term liabilities | -161,111 | 161,111 | |||||||
| share issue | |||||||||
| interest | |||||||||
| cash flow from financing | |||||||||
| cash and cash equivalents | |||||||||
| cash | -101,646 | 116,145 | 14,306 | 88,910 | -3,146 | 11,543 | -16,248 | 13,226 | 15,449 |
| overdraft | -50,000 | 50,000 | |||||||
| change in cash | -101,646 | 116,145 | 64,306 | 38,910 | -3,146 | 11,543 | -16,248 | 13,226 | 15,449 |
ote pharma uk limited Credit Report and Business Information
Ote Pharma Uk Limited Competitor Analysis
Perform a competitor analysis for ote pharma uk limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in HA7 area or any other competitors across 12 key performance metrics.
ote pharma uk limited Ownership
OTE PHARMA UK LIMITED group structure
Ote Pharma Uk Limited has no subsidiary companies.
Ultimate parent company
OTE HOLDING BV
#0106685
1 parent
OTE PHARMA UK LIMITED
09278402
ote pharma uk limited directors
Ote Pharma Uk Limited currently has 1 director, Mrs Deirdre Beth serving since Oct 2014.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mrs Deirdre Beth | 72 years | Oct 2014 | - | Director |
P&L
December 2023turnover
1.3m
+1%
operating profit
895.8k
0%
gross margin
27.6%
-0.71%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
1.2m
+1.23%
total assets
1.5m
+0.59%
cash
138.5k
-0.42%
net assets
Total assets minus all liabilities
ote pharma uk limited company details
company number
09278402
Type
Private limited with Share Capital
industry
46900 - Non-specialised wholesale trade
incorporation date
October 2014
age
11
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
December 2023
previous names
N/A
accountant
PARKER CAVENDISH
auditor
-
address
28 church road, stanmore, middlesex, HA7 4XR
Bank
-
Legal Advisor
-
ote pharma uk limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ote pharma uk limited.
ote pharma uk limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for OTE PHARMA UK LIMITED. This can take several minutes, an email will notify you when this has completed.
ote pharma uk limited Companies House Filings - See Documents
| date | description | view/download |
|---|
